COVID-19 as a Risk Factor for Alzheimer's Disease

M Golzari-Sorkheh, DF Weaver… - Journal of Alzheimer's …, 2023 - content.iospress.com
Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease …

[HTML][HTML] Focus: climate change and environmental health: heat and the heart

Y Desai, H Khraishah, B Alahmad - The Yale Journal of Biology …, 2023 - ncbi.nlm.nih.gov
Globally, more people die from cardiovascular disease than any other cause. Extreme heat
can have serious implications for heart health, especially in people with pre-existing …

Alterations to Kidney Physiology during Cardiopulmonary Bypass—A Narrative Review of the Literature and Practical Remarks

J Udzik, J Pacholewicz, A Biskupski… - Journal of Clinical …, 2023 - mdpi.com
Introduction: According to different authors, cardiac surgery-associated acute kidney injury
(CSA-AKI) incidence can be as high as 20–50%. This complication increases postoperative …

Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols

E Elekhnawy, WA Negm, SA El-Sherbeni… - Inflammopharmacology, 2022 - Springer
The pandemic spread of coronavirus (COVID-19) has been reported first at the end of 2019.
It continues disturbing various human aspects with multiple pandemic waves showing more …

[HTML][HTML] Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its …

J Diaz-Martinez, W Kotzker, MA Mendoza-Hernandez… - Pharmaceutics, 2024 - mdpi.com
In the ongoing fight against Coronavirus Disease 2019 (COVID-19), researchers are
exploring potential treatments to improve outcomes, especially in severe cases. This …

Comprehensive analysis of prohibited substances and methods in sports: unveiling trends, pharmacokinetics, and WADA evolution

P Oleksak, E Nepovimova, M Valko, S Alwasel… - Environmental …, 2024 - Elsevier
This review systematically compiles sports-related drugs, substances, and methodologies
based on the 2023 Prohibited List. Aligned with the list's structure, it covers all proscribed …

Several first-line anti-hypertensives act on fibrosarcoma progression and PD1ab blockade therapy

J Sun, C Zhang, X Su, H Zhou, S Zhou, M Jiang… - Journal of Orthopaedic …, 2024 - Springer
Purpose Patients are typically diagnosed with both hypertension and fibrosarcoma. Medical
oncologists must prescribe suitable anti-hypertensive medications while considering anti …

Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment

J Zhao, F Xia, X Jiao, X Lyu - Frontiers in Neurology, 2024 - frontiersin.org
Corona Virus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), has presented unprecedented challenges to the world …

Diuretic drug utilization in neonates: a French prescription database analysis

S Iacobelli, S Lorrain, E Rabe, B Gouyon… - Frontiers in …, 2024 - frontiersin.org
Background: The use of diuretics is extremely common in infants cared for in neonatal
wards, despite the lack of proven efficacy for many conditions. The main objective of this …

[HTML][HTML] Sex Differences on the Pharmacokinetics of Drugs for Children with Chronic Kidney Disease: A Narrative Review

T Faghihi, F Assadi - Advanced Pharmaceutical Bulletin, 2024 - pmc.ncbi.nlm.nih.gov
Effective optimal pharmacotherapy requires a comprehensive understanding of the drug's
pharmacokinetic properties. Chronic kidney disease (CKD) influences medication …